Firestone Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$863K Sell
3,969
-22
-0.6% -$4.88K 0.18% 71
2025
Q4
$912K Sell
3,991
-5
-0.1% -$1.14K 0.19% 67
2025
Q3
$925K Hold
3,996
0.2% 67
2025
Q2
$742K Hold
3,996
0.17% 71
2025
Q1
$837K Buy
3,996
+2,511
+169% +$488K 0.22% 61
2024
Q4
$264K Sell
1,485
-100
-6% -$18.4K 0.07% 131
2024
Q3
$313K Hold
1,585
0.08% 115
2024
Q2
$272K Hold
1,585
0.07% 120
2024
Q1
$289K Hold
1,585
0.08% 112
2023
Q4
$246K Hold
1,585
0.08% 115
2023
Q3
$236K Hold
1,585
0.08% 109
2023
Q2
$214K Hold
1,585
0.07% 123
2023
Q1
$253K Buy
+1,585
New +$242K 0.09% 95
2021
Q4
Sell
-585
Closed -$66K 124
2021
Q3
$66K Hold
585
0.02% 211
2021
Q2
$66K Hold
585
0.02% 206
2021
Q1
$63K Hold
585
0.02% 206
2020
Q4
$63K Hold
585
0.02% 197
2020
Q3
$51K Hold
585
0.02% 188
2020
Q2
$57K Hold
585
0.03% 178
2020
Q1
$45K Hold
585
0.02% 187
2019
Q4
$52K Buy
+585
New +$48.6K 0.02% 204

Other funds holding ABBV

Firestone Capital Management's ABBV Position: Q1 2026 in Review

Firestone Capital Management reduced its AbbVie (ABBV) stake by 0.55% in Q1 2026, selling an estimated $4.88K and leaving 3,969 shares worth $863K. The position accounts for 0.18% of the portfolio, ranked #71.

Firestone Capital Management first reported a position in ABBV in Q4 2019 and has held it in 21 quarters since. The position peaked at $925K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Firestone Capital Management held 3,969 shares of AbbVie worth $863K as of Q1 2026.
  • Firestone Capital Management sold 22 AbbVie shares in Q1 2026, an estimated $4.88K.
  • AbbVie made up 0.18% of Firestone Capital Management's portfolio in Q1 2026, its #71 holding.
  • Firestone Capital Management first reported a position in AbbVie in Q4 2019 and has held it in 21 quarters since.
  • Firestone Capital Management's AbbVie position peaked at $925K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Firestone Capital Management's 13F filing for Q1 2026, filed 8 May 2026.